HTGM info is a resource platform meant for internal use by Housing Trust Group employees.

HTGM info

HTG Management | 243 followers on LinkedIn. We develop multifamily residential communities and are one of the nation’s leading developers of affordable housing. | Housing Trust Group (HTG) is an award-winning full-service developer of multifamily residential communities and one of the nation’s leading developers of affordable housing. HTG was named one of Real Estate Forum magazine&#39;s fastest growing businesses in 2016. HTG develops, builds, and manages a diverse portfolio of affordable housing, workforce housing, market-rate housing, and mixed-use developments.

Assistant Property Manager

Yaimi Rodriguez

Director Of Operations at HTGM

Carlos Insuasty

Cortney Stark

Business Owners / Director/ Management/

Sarah Israel

HTG Management

Domain Not Resolving

Apple Mobile Web Clips Icon

DNSSEC

Organization Schema

reCAPTCHA

Sitelinks Search Box

Yoast WordPress SEO Plugin

Yoast SEO Premium

Apple Mobile Web App Capable

Apache 2.4

Board Member

Ann Hanham

President and Chief Executive Officer

John Lubniewski

Software QA Engineer at American Board of Radiology

Mike Copeland

Owner

Sam Rua

Senior Vice President of Finance, Administration and Chief Financial Officer

Shaun McMeans

Founder/CEO @ Stealth Biotech

Steven Lung

Founder

Sue Pierce

Senior Vice President Finance and Administration

Laura Godlewski

SVP, Research and Development

Marian Navratil

VP Strategic Partnerships

Peter Riefenhauser

Don Grimm

Timothy Yeatman

Lewis Shuster

Larry Senour

Peter Bisgaard

Don Hardison

Harry George

Ann F. Hanham

Bruce E. Seligmann

Debra Gordon

Vice President, Chief Legal Counsel

Vice President of Finance, Administration and CFO

BJ Kerns

VP, Scientific Collaborations

Patrick Roche

HTG Molecular Diagnostics

VP, Pharma Partnerships and Scientific Collaborations

Kirk A. Collamer

VP and CFO

Biotechnology Companies With Less Than $1B in Revenue (Top 10K)

Biotechnology Companies that Exited

Life Science Public Companies

Western US Public Companies

HTG Molecular Diagnostics is a provider of molecular-based technology solutions for gene expression profiling, miRNA, siRNA and mRNA measurement for translational medicine and diagnostic applications. 

The Company's NGS-adapted chemistry and HTG EdgeSeq technology automate sample processing and can swiftly, reliably, and concurrently profile hundreds or thousands of molecular targets utilizing a very little quantity of biological material, in liquid or solid form. Its products comprise equipment, consumables, and software that work together to form the HTG EdgeSeq platform. The HTG EdgeSeq platform automates the company's menu of HTG EdgeSeq molecular profiling panels, which use genomic sequencing techniques to swiftly provide gene expression data for clients utilizing its streamlined approach. 

HTG Molecular Diagnostics was established in 1997 by Bruce E. Seligmann in Tucson, Arizona.

Post-IPO Equity - HTG Molecular Diagnostics

Debt Financing - HTG Molecular Diagnostics

Series E - HTG Molecular Diagnostics

Venture Round - HTG Molecular Diagnostics

SR One

Series D - HTG Molecular Diagnostics

Series C - HTG Molecular Diagnostics

Tucson

Arizona

United States

North America

65H.BE Purchase Info | Investment Information for HTG Molecular Diagnostics Inc Stock

Genetic Testing Market Set for Major Growth, Achieving a 9.7% CAGR Through 2032

HTG Molecular Diagnostics Q1 Loss Per Share $0.08

HTG Molecular Diagnostics signs distribution deals in Israel, Europe

Cash from investing activities of HTG MOLECULAR DIAGNOSTICS INC. – SWB:65H – TradingView

Genetic Testing Market revenue to reach USD 45 Billion by 2035, says Research Nester

Here's how Arizona bioscience construction boom impacts ...

Orthofix (OFIX) Q2 Earnings and Revenues Surpass Estimates

TransMedics (TMDX) Reports Q2 Loss, Tops Revenue ...

Why Are HTG Molecular Diagnostics Shares Plunging Today

A tool for full transcriptome profiling to support drug and companion diagnostic discovery across various disease areas.

A technology for profiling RNA modifications to aid in drug discovery by analyzing epitranscriptomic data.

Combines transcriptome mining with medicinal chemistry and computational filters for screening molecular targets in disease research.

Focuses on RNA-Modifying Proteins and other targets for diseases like Oncology, AutoImmune, Neurodegenerative, and Rare Diseases.

India

Asia

Canada

Russian Federation

Europe

Czech Republic

HTML5

Google Fonts

Comodo PositiveSSL Certificates

Google Doubleclick

Apache Server

Microsoft Outlook

Google Tag Manager

Google Drive

Vimeo

Google Analytics

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 17, 2024 9:41 AM	f175be1e
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 17, 2024 9:41 AM	87843ef9
crunchbase trigger	general	Nov 17, 2024 9:41 AM	af810c41
crunchbase profile	general	Nov 17, 2024 11:41 AM	95c08f54
li profile	general	Nov 17, 2024 9:41 AM	4134814d
translate crunchbase fundingrounds	general	Nov 17, 2024 12:05 PM	c55c90a5
peers	general	Nov 17, 2024 9:41 AM	a7037918
news basic	general	Nov 17, 2024 9:41 AM	fb834a7d
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

HTGM

INFO:HTGM

HTGM info